tiopronin has been researched along with Liver Neoplasms in 2 studies
Tiopronin: Sulfhydryl acylated derivative of GLYCINE.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hepatotoxicity induced by sorafenib and antiviral therapy is a limitation for its continuation treatment for patients with advanced hepatitis B virus-related hepatocellular carcinoma (HCC)." | 9.20 | Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma. ( Guo, W; Li, J; Qiu, X; Yan, B; Zhang, S, 2015) |
| "Hepatotoxicity induced by sorafenib and antiviral therapy is a limitation for its continuation treatment for patients with advanced hepatitis B virus-related hepatocellular carcinoma (HCC)." | 5.20 | Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma. ( Guo, W; Li, J; Qiu, X; Yan, B; Zhang, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sano, N | 1 |
| Yoshino, H | 1 |
| Sato, Y | 1 |
| Honma, H | 1 |
| Cordonier, CEJ | 1 |
| Kashiwakura, I | 1 |
| Li, J | 1 |
| Qiu, X | 1 |
| Guo, W | 1 |
| Yan, B | 1 |
| Zhang, S | 1 |
1 trial available for tiopronin and Liver Neoplasms
| Article | Year |
|---|---|
Prospective analysis of tiopronin in prevention of sorafenib and antiviral therapy inducing liver toxicity in advanced hepatitis B virus-related hepatocellular carcinoma.
Topics: Antineoplastic Agents; Antiviral Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; Femal | 2015 |
1 other study available for tiopronin and Liver Neoplasms
| Article | Year |
|---|---|
Cytotoxic Activity of Unique Synthesized Five-membered Heterocyclic Compounds Coordinated with Tiopronin Monovalent.
Topics: Antineoplastic Agents; Cell Line; Heterocyclic Compounds; Humans; Liver Neoplasms; Tiopronin | 2023 |